Liverpool School of Tropical Medicine will work with the Medicines Patent Pool (MPP) to embed access plans in licensing agreements for early-stage medical technology.

This is the most recent out of various commitments that the MPP has secured from licensors and funders of early-stage technologies.
πŸ“’ MPP & @lstmnews.bsky.social signed a MOU to enhance global access to LSTM’s IP portfolio. 🌍✨

πŸ™Œ This collaboration aims to incorporate access-oriented clauses in LSTM agreements, such as an affordable access plan provision in licences for early-stage medical tech.

πŸ”— bit.ly/40eQYDt

Comments